Loading...

VOR VOR BIOPHARMA INC Management Changes 8-K Filing

VR B

VR

VOR BIOPHARMA INC

(VOR)

2025 8-K

Summary

Summary

Stock Split Update

Corporate Presentation Update

Management Changes

Stockholder Approval

Licensing Agreement

Equity Offerings

Workforce Reduction

Noncompliance with Listing ...

Management Change

Stock Option Repricing

Board Appointment

Private Placement

Clinical Data Update

CFO Appointment

Resignation and Appointment

Equity Incentive Plan Amend...

Appointment of Director

Clinical Update

Annual Meeting of Stockholders

Resignation of Director

Clinical Update

External Links:

Vor Biopharma Inc. announced on July 16, 2025, that Dr. Sven Lundberg resigned from the Board, and Dr. Qing Zuraw was appointed as Chief Development Officer with a salary of $565,000; also, Michel Detheux and Alexander Cumbo joined as directors.

AI Assistant

VOR BIOPHARMA INC

2025

8 K

Find Answers

Ask about any part of the document to get insights, explanations, or key details.